Drug recall · June 19, 2019
Lotemax recall
Why: Failed Stability Specifications: Out of specification for viscosity.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lotemax (loteprednol etabonate ophthalmic gel 0.5%), Sterile, Rx Only, 5 g box, Bausch & Lomb, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA, NDC 24208-503-07.
- Lots / codes
Lot #s: 282611; 283431; 283441; 283451, Exp. 10/2019; 282971; 282981; 283611; 283621; 283631, Exp. 11/2019.
- Quantity
- 170832 bottles
- Company
- Bausch & Lomb, Tampa, FL
- Distribution
- Nationwide in the U.S.
- Initiated
- June 17, 2019 · Voluntary: Firm initiated
- Classified
- June 19, 2019
- Reported
- June 19, 2019
- Ended
- September 24, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lotemax
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.